Donate For Public and Patients Store Search

F038 - Skin of Color Boot Camp: What Every Dermatologist Should Know About the Patient with Darker Skin Tones

Friday, March 1; 3:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Improve clinician confidence with medical management for disorders common in patients with darker skin tones
  • Provide a quick and accurate assessment approach
  • Provide treatment algorithms

Description

This session provides a practical and comprehensive overview to assist clinicians in optimizing the care of the skin of color patient. Diagnostic and treatment algorithms will be provided. Topics will include hyperpigmentation, acne, cosmetic enhancement, keloids, acne keloidalis niche, pseudofolliculitis barber, scalp disorders and alopecia.

Disclosures

  • Barbosa, Victoria Holloway, MD: no financial relationships exist with commercial interests.
  • Burgess, Cheryl M., MD: Aclaris Therapeutics Inc. – I(Grants/Research Funding), SP(H); Allergan, Inc. – I(Grants/Research Funding), SH(ST); Dermira – SP(H); Galderma USA – A(H); Kythera – I(Grants/Research Funding); Merz Aesthetics – A(H), I(Grants/Research Funding); Revance Therapeutics, Inc. – I(Grants/Research Funding); Sinclair Pharma – A(H);
  • Callender, Valerie D., MD: Aerolase – A(H); Allergan, Inc – I(Grants/Research Funding), SP(H); Allergan, Inc. – C(H); Almirall – SP(H); Dermira – SP(H); Eli Lilly and Company – I(Grants/Research Funding); Menlo Therapeutics – A(H), I(Grants/Research Funding); Merz Aesthetics – Speaker/Faculty Education(H); Othro Dermatologics – I(Grants/Research Funding); PCA SKIN – A(H); Pfizer Inc. – I(Grants/Research Funding), SP(H); Unilever Home & Personal Care USA – A(H);
  • McMichael, Amy J., MD: Aclaris Therapeutics Inc. – C(H), I(Grants/Research Funding); Allergan, Inc. – C(H), I(OB); Anacor Pharmaceuticals, Inc. – A(H); Cassiopea S.p.A. – I(Grants/Research Funding); Concert Pharmaceuticals – I(Grants/Research Funding); Galderma Laboratories, L.P. – C(OB); Incyte Corporation – C(H), I(Grants/Research Funding); Informa – O(OB); JAMA – O(NC); Johnson & Johnson Consumer Products Company – C(H); NAAF – A(NC); North American Hair Research Society – B(NC); Procter & Gamble Company – C(H), I(OB); Samumed, LLC – C(H); UpToDate, Inc – Speaker/Faculty Education(H);
  • Taylor, Susan C., MD: Aclaris Therapeutics, Inc. – A(H), I(Grants/Research Funding), SP(H); Allergan, Inc – A(H), Speaker/Faculty Education(NC); Almirall – A(H); Avon Products, Inc. – C(H); Beiersdorf, Inc. – A(H), C(H), Speaker/Faculty Education(H); Boots – A(H); CannTec – B(H); Croma-Pharma GmbH Austria – I(Grants/Research Funding); Eli Lilly and Company – I(Grants/Research Funding); Galderma Laboratories, L.P. – A(H); Galderma Laboratories, LP – Speaker/Faculty Education(H); Johnson & Johnson Consumer Products Company – A(H); KGL Skin Study Center – Independent Contractor(S); Neostrata – C(H); Unilever – SP(H);
Schedule
Friday, March 1
3:30 PM
Dr. Taylor / Introduction
3:35 PM
Dr. McMichael / Approach to hair and scalp disorders in skin of color patients
4:00 PM
Dr. Callender / Approach to acne and rosacea in skin of color patients
4:25 PM
Dr. Taylor / Approach to the skin of color patient with facial hyperpigmentation
4:50 PM
Dr. Barbosa / Approach to the male skin of color patient
5:15 PM
Dr. Burgess / Cosmetic enhancement for the pigmented patient
Event Details
  • Date
    Friday, March 1
  • Time
    3:30 PM - 5:30 PM
  • Location
    Room 146A
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
  • Susan C. Taylor, MD, FAAD
Speakers
  • Amy J. McMichael, MD, FAAD
  • Cheryl M. Burgess, MD, FAAD
  • Valerie D. Callender, MD, FAAD
  • Victoria Holloway Barbosa, MD, FAAD